^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    ZBTB16-RARA fusion

    i
    Other names: ZBTB16, Zinc Finger And BTB Domain Containing 16, Zinc Finger Protein 145 (Kruppel-Like, Expressed In Promyelocytic Leukemia), Zinc Finger And BTB Domain-Containing Protein 16, Promyelocytic Leukaemia Zinc Finger, Zinc Finger Protein PLZF, ZNF145, PLZF, Promyelocytic Leukemia Zinc Finger Protein, Zinc Finger Protein 145, RARA, Retinoic Acid Receptor Alpha, Nuclear Receptor Subfamily 1 Group B Member 1, RAR-Alpha, NR1B1, Nucleophosmin-Retinoic Acid Receptor Alpha Fusion Protein NPM-RAR Long Form,
    Entrez ID:
    5914; 7704
    Related biomarkers:
    Expression
    Fusion
    Others
    2years
    Morphological characterization of acute myeloid leukaemia with t(11;17)(q23;q21)/ZBTB16::RARA fusion. (PubMed, Br J Haematol)
    No abstract available
    Journal
    |
    ZBTB16 (Zinc Finger And BTB Domain Containing 16)
    |
    ZBTB16-RARA fusion
    over3years
    Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia. (PubMed, Cancer Med)
    Our data suggest the association of mutations of the ARID1A gene and of the other members of the SWI/SNF chromatin remodeling complexes with ZBTB16-RARA+AMLs, where they may support the peculiar disease phenotype.
    Journal
    |
    ARID1A (AT-rich interaction domain 1A) • SMARCA4 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily A, member 4) • ARID2 (AT-Rich Interaction Domain 2) • ZBTB16 (Zinc Finger And BTB Domain Containing 16)
    |
    ARID1A mutation • SMARCA4 mutation • RARA positive • ZBTB16-RARA fusion